Rajni Aneja
Strategic Executive, Clinical Transformation Leader, Humana |
 |
Philippe Lopes-Fernandes
VP and Head, Global Business Development, Merck Serono |
Jeff Arnold
President, Arnold Strategies LLC |
|
Daniel Lynch
Venture Partner, Third Rock Ventures |
St�phane Bancel
President and Founding CEO, Moderna Therapeutics |
|
Geoff MacKay
President and CEO, Organogenesis |
Karen Becker
Managing Director, Regulatory Sciences, Precision for Medicine |
|
Lee McCracken
Former President and CEO, Pathwork Diagnostics |
Katrine Bosley
Independent Director, Galapagos; Independent Board Member, Genocea |
|
John McNeish
Head of Research, Regenerative Medicine DPU, GlaxoSmithKline |
Richard Brudnick
VP, Co-Head BD/M&A, Biogen Idec |
|
Jonathan Montagu
VP, Business Development and Operations, Nimbus Discovery, Inc. |
Pamela Carroll
VP, Oncology Scientific Innovation, Janssen Pharmaceutical Companies of Johnson & Johnson |
|
Frank Moss
Co-Founder, Atelion Health and Matter.io |
David Collier
CEO, Velocity Pharmaceutical Development |
|
Imran Nasrullah
Head, Strategic Alliances, T1D Exchange |
Christine Copple
CEO, Starise Ventures, Inc. |
|
Garry Neil
Partner, Apple Tree Partners; Chairman TransCelerate BioPharma Inc. |
Alan Crane
General Partner, Polaris Partners |
|
Walter Ogier
CEO, Acetylon Pharmaceuticals Inc. |
Bernard Davitian
VP, BD Licensing and Structured Investments, Sanofi |
|
Kush Parmar
Principal, 5AM Ventures |
Christopher J. Denn
Partner, Life Sciences, Goodwin Procter |
|
Christoph Pittius
VP, Strategic Partnering and Business Development, Cardiovascular/Metabolic, AstraZeneca |
Sheila DeWitt
President and CEO, DeuteRx LLC |
|
Jeff Poulton
Rare Disease Business Unit Head (interim), Shire Pharmaceuticals |
Steven Dickman
CEO, CBT Advisors |
|
Jeffrey L. Quillen
Partner, Foley Hoag LLP |
Sara Elinson
Principal, Deloitte Financial Advisory Services LLP |
|
Kareem S. Reda
Associate Director, Business Development, Celgene |
Adam Feuerstein
Senior Columnist, TheStreet |
|
Kiran Reddy
Interim Chief Business Officer, SAGE Therapeutics |
Brian Gallagher, Jr.
Partner, SR One |
|
Brock Reeve
Executive Director, Harvard Stem Cell Institute |
Roger Garceau
Executive VP and Chief Medical Officer, NPS Pharmaceuticals |
|
Jason Rhodes
President and CFO, Epizyme |
Jim Geraghty
Entrepreneur-in-Residence, Third Rock Ventures and Chairman, Idera Pharmaceuticals |
|
Morrie Ruffin
Managing Partner, Adjuvant Partners |
Michael Gilman
Former Founder and CEO, Stromedix |
|
Ed Saltzman
President, Defined Health |
Tim Gordon
Partner, America FAAS, Life Sciences Leader, Ernst & Young |
|
Atul Saran
VP, Corporate Development and Ventures, AstraZeneca |
Carol Greve-Philips
CBO, Pronota |
|
Dale Schenk
CEO, Prothena |
Magali Haas
Founder and CEO, Orion Bionetworks |
|
Stanley Shaw
Co-Director, Chemical Biology, MGH Center for Systems Biology; Co-Founder, Co-Director MGH Center for Assessment Technology and Continuous Health (CATCH) |
Erik Halvorsen
Executive Director, Technology and Innovation Development Office; Managing Partner, Technology Development Fund, Boston Children's Hospital |
|
David Silbersweig
Chairman, Department of Psychiatry, Co-Director, Institute for the Neurosciences, Brigham and Women’s Hospital; Stanley Cobb Professor of Psychiatry, HMS Dean for Academic Programs, Partners Healthcare, Harvard Medical School |
Arthur Hiller
CEO, SciFluor Life Sciences |
|
Catherine Angell Sohn
Board of Directors, Landec Corporation |
Stephen J. Hoffman
Managing Director, Skyline Ventures |
|
Kumar Srinivasan
VP, Scientific Partnering and Alliances, AstraZeneca |
Peter K. Honig
Head, Global Regulatory Affairs, Patient Safety, and Quality Assurance, AstraZeneca |
|
Steven Tregay
Founder, President and CEO, FORMA Therapeutics |
Martin Jefson
CSO, Rodin Therapeutics |
|
Robert Urban
Head, Johnson & Johnson Boston Innovation Center |
Kevin Johnson
Partner, Index Ventures |
|
Karin Van Baelen
Head Global Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson |
Iya Khalil
Executive VP and Co-Founder, GNS Healthcare |
|
Gil Van Bokkelen
Chairman and CEO, Athersys, Inc. |
Isaac T. Kohlberg
Senior Associate Provost, Chief Technology Department Officer, Harvard University |
|
Sander van Deventer
General Partner, Forbion Capital Partners |
Sandra Kuzmich
Partner, Frommer, Lawrence & Haug LLP |
|
Robin Wright
CFO, Karolinska Development AB |
D. Kevin Kwok
Managing Director and Head, North American Pharma/Biotech, Russell Reynolds Associates |
|
Krishna Yeshwant
General Partner, Google Ventures |
Nick Leschly
chief bluebird, bluebird bio |
|
Todd Zion
President and CEO, Akston Biosciences Corp. |
Mark Leuchtenberger
Former CEO, Rib-X Pharmaceuticals |
|
Daphne Zohar
Founder, Managing Partner, PureTech Ventures |
Brian Loew
Founder and CEO, Inspire |
|
|
